Kidney failure

Elderly Nutrition Market Research Report 2022: Featuring Key Players Abbott, Danone, Pfizer, Nestle & Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 17, 2022 - 10:03am

This research report categorizes the Elderly Nutrition to forecast the revenues and analyze the trends in each of the following sub-markets:

Key Points: 
  • This research report categorizes the Elderly Nutrition to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Type, the market was studied across Antioxidants, Fibers, Iron, Lipids, Minerals, Multi-vitamins, and Proteins.
  • Based on Application, the market was studied across Cancer, Cancer, Diabetes, Obesity, Renal Failure, and Sarcopenia.
  • Based on Distribution, the market was studied across Hospitals, Online, and Retail Drug Store.
  • The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market.

OUTSET MEDICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Outset Medical, Inc. - OM

Retrieved on: 
Wednesday, August 17, 2022 - 3:54am

This action is pending in the United States District Court for the Northern District of California.

Key Points: 
  • This action is pending in the United States District Court for the Northern District of California.
  • Outset investors should visit us at https://claimsfiler.com/cases/nasdaq-om/ or call toll-free (844) 367-9658.
  • CareDx and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
  • Outset and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

OUTSET MEDICAL, INC. (NASDAQ: OM) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Outset Medical, Inc. (NASDAQ: OM)

Retrieved on: 
Monday, August 15, 2022 - 9:00pm

NEW YORK, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Outset Medical, Inc. (“Outset Medical” or the “Company”) (NASDAQ: OM) between September 15, 2020, and June 13, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Exchange Act of 1934.
  • Outset Medical is a medical technology company focused on kidney dialysis, the primary treatment for acute and chronic kidney failure.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Outset Medical, Inc. (OM) Investors and Encourages Investors to Contact the Firm Before September 6, 2022

Retrieved on: 
Friday, August 12, 2022 - 11:55pm

Investors have until September 6, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until September 6, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Outset is a medical technology company focused on kidney dialysis, the primary treatment for acute and chronic kidney failure.
  • Kirby McInerney LLP is a New York-based plaintiffs law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.
  • The firms efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Wells Fargo, Unity, Amazon, and Outset Medical and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, August 11, 2022 - 2:00am

On June 6, 2022, Reuters published an article entitled Wells Fargo Pauses Diverse Slate Hiring Policy after Reports of Fake Job Interviews.

Key Points: 
  • On June 6, 2022, Reuters published an article entitled Wells Fargo Pauses Diverse Slate Hiring Policy after Reports of Fake Job Interviews.
  • Then, on June 9, 2022, the New York Times published an article entitled Federal Prosecutors Open Criminal Inquiry of Wells Fargos Hiring Practices.
  • For more information on the Wells Fargo class action go to: https://bespc.com/cases/WFC
    Unity creates and operates an interactive real-time 3D content platform.
  • For more information on the Outset Medical class action go to: https://bespc.com/cases/OM
    About Bragar Eagel & Squire, P.C.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Outset Medical, Inc. (OM)

Retrieved on: 
Wednesday, August 10, 2022 - 4:00pm

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.
  • On May 4, 2022, after the market closed, Outset disclosed disappointing results for first quarter 2022, including a net loss of $35.9 million.
  • Analysts attributed the results to the unproven reliability of the Companys Tablo Hemodialysis System (Tablo) for kidney failure patients.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

OUTSET MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Outset Medical, Inc. - OM

Retrieved on: 
Wednesday, August 10, 2022 - 4:05am

This action is pending in the United States District Court for the Northern District of California.

Key Points: 
  • This action is pending in the United States District Court for the Northern District of California.
  • If you wish to serve as a lead plaintiff in this class action, you must petition the Court by September 6, 2022.
  • Outset and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
  • About Kahn Swick & Foti, LLC
    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nations premier boutique securities litigation law firms.

SAB Biotherapeutics Advancing Pipeline and Expands into Treatment for C. Diff. as DoD Contract Winds Down

Retrieved on: 
Tuesday, August 9, 2022 - 9:30pm

We wish to thank our DoD partners for their support, collaboration, and belief in SABs science.

Key Points: 
  • We wish to thank our DoD partners for their support, collaboration, and belief in SABs science.
  • We stand ready to support our nations men and women in uniform as they address our national security needs.
  • SAB has advanced its preclinical program, SAB-195, a polyclonal antibody treatment for C.
  • The CDC estimates that about 500,000 people are infected per year and about 30,000 patients die annually from C. diff.

OUTSET MEDICAL, INC. (NASDAQ: OM) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Outset Medical, Inc. (NASDAQ: OM)

Retrieved on: 
Monday, August 8, 2022 - 9:00pm

NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Outset Medical, Inc. (“Outset Medical” or the “Company”) (NASDAQ: OM) between September 15, 2020, and June 13, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Exchange Act of 1934.
  • Outset Medical is a medical technology company focused on kidney dialysis, the primary treatment for acute and chronic kidney failure.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Wells Fargo, Unity, Amazon, and Outset Medical and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, August 6, 2022 - 2:00am

On June 6, 2022, Reuters published an article entitled Wells Fargo Pauses Diverse Slate Hiring Policy after Reports of Fake Job Interviews.

Key Points: 
  • On June 6, 2022, Reuters published an article entitled Wells Fargo Pauses Diverse Slate Hiring Policy after Reports of Fake Job Interviews.
  • Then, on June 9, 2022, the New York Times published an article entitled Federal Prosecutors Open Criminal Inquiry of Wells Fargos Hiring Practices.
  • For more information on the Wells Fargo class action go to: https://bespc.com/cases/WFC
    Unity creates and operates an interactive real-time 3D content platform.
  • For more information on the Outset Medical class action go to: https://bespc.com/cases/OM
    About Bragar Eagel & Squire, P.C.